Midline Volume Filler Injection for Facial Rejuvenation and Contouring in Asians

轮廓 眉间 医学 前额 面部修复 返老还童 可视模拟标度 鼻子 鼻整形术 填料(材料) 下巴 体积热力学 尸体痉挛 整形外科 外科 耳鼻咽喉科 身体轮廓 眼睑成形术 鼻唇沟 疤痕 口腔正畸科 皱纹 眉毛 软组织 患者满意度 解剖 工程制图 工程类 物理 老年学 量子力学
作者
Zhenhua Xiong,Zhengzheng Jiang,Kai Li
出处
期刊:Aesthetic Plastic Surgery [Springer Science+Business Media]
卷期号:43 (6): 1624-1634 被引量:8
标识
DOI:10.1007/s00266-019-01498-z
摘要

Hyaluronic acid (HA) injection is popular in cosmetic surgery because of its minimal invasion and immediate recovery. However, few injection techniques are specifically designed for Asians, considering their aesthetic and structural differences from those of Caucasians. The midline volume injection technique was performed on 37 Asian females and 3 males at sites including the forehead, glabella, nasal dorsum, nasal base and chin. The treatment focused on improving the facial profile projection. 3D image data were collected, and facial aesthetic angles were calculated. Volume changes in facial parts were analyzed before injection and during follow-up. Patient satisfaction was assessed using the visual analog scale (VAS). The average injected filler volume was 6.14 ± 2.82 ml. The treatment optimized the facial contour and produced instant facial rejuvenation. On 3D images, the average midline volume increased by 6.02 ± 2.23 ml. An average volume decrease of 3.92 ± 1.94 ml was observed in the cheeks and was positively related to the increased midline volume. The average nasolabial and nasal facial angles were increased from 100.00 ± 7.37° to 107.93 ± 9.01° and 28.78 ± 3.28° to 31.78 ± 2.97°, while the mentolabial angle was decreased from 146.55 ± 7.83° to 141.13 ± 6.23°. The mean VAS scores were 2.28 ± 1.27 immediately after injection and 2.56 ± 1.20 after 6 months. The midline volume injection technique of HA fillers is suitable for Asians. It greatly enhances the facial profile, as illustrated by volume changes in 3D images, leading to a more attractive facial appearance. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
哈哈哈完成签到,获得积分10
1秒前
SYLH应助科研通管家采纳,获得10
2秒前
Akim应助科研通管家采纳,获得10
2秒前
共享精神应助科研通管家采纳,获得10
2秒前
丘比特应助科研通管家采纳,获得10
2秒前
2秒前
上官若男应助科研通管家采纳,获得10
2秒前
orixero应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
三旬完成签到,获得积分10
4秒前
雨水发布了新的文献求助10
5秒前
6秒前
wwwwwwwwwwww完成签到 ,获得积分10
6秒前
Lucas应助lllll采纳,获得10
7秒前
852应助zhang采纳,获得10
9秒前
英姑应助现代雪晴采纳,获得10
9秒前
CipherSage应助陈博文采纳,获得10
10秒前
一颗柠檬完成签到,获得积分10
10秒前
量子星尘发布了新的文献求助10
11秒前
11秒前
12秒前
17发布了新的文献求助10
12秒前
小葛发布了新的文献求助10
12秒前
丘比特应助菠萝蜜采纳,获得10
13秒前
16秒前
科研通AI2S应助刘春秀采纳,获得10
17秒前
18秒前
JUDY完成签到,获得积分10
18秒前
啊喂发布了新的文献求助10
19秒前
20秒前
21秒前
马麻薯完成签到,获得积分10
21秒前
21秒前
enndyou完成签到,获得积分10
23秒前
星黛Lu完成签到,获得积分10
24秒前
康康发布了新的文献求助10
26秒前
传奇3应助陶醉晓凡采纳,获得10
26秒前
26秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
Comparison of adverse drug reactions of heparin and its derivates in the European Economic Area based on data from EudraVigilance between 2017 and 2021 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3952701
求助须知:如何正确求助?哪些是违规求助? 3498211
关于积分的说明 11090706
捐赠科研通 3228753
什么是DOI,文献DOI怎么找? 1785094
邀请新用户注册赠送积分活动 869086
科研通“疑难数据库(出版商)”最低求助积分说明 801350